SCHEMBL5317855

SCHEMBL5317855

CN(C)c1cccc(C(=O)O)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.61
TDP1 Q9NUW8 2/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 1/20 0.61
ACMSD Q8TDX5 1/20 0.61
LMNA P02545 4/20 0.49
ECE1 P42892 1/20 0.44
GNE Q9Y223 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
MGAM O43451 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15652380 0.82 PIM1 (0.43) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL19065189 0.82 KDM4E (0.53) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL18246722 0.79 MAPT (0.49) KDM4ETDP1TSHRLMNAALDH1A1
SCHEMBL7492564 0.79 KDM4E (0.55) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL2641612 0.79 KDM4E (0.50) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL2638747 0.79 KDM4E (0.50) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL18246600 0.78 P2RX7 (0.62) KDM4ETDP1LMNAALDH1A1L3MBTL1
SCHEMBL28804101 0.78 KDM4E (0.48) KDM4ETDP1ALOX15TSHRACMSD
Dipicolinic Acid SCHEMBL720696 0.78 KDM4E (1.00) KDM4ETDP1ALOX15TSHRACMSD
Dipicolinic Acid SCHEMBL34595 0.78 KDM4E (1.00) KDM4ETDP1ALOX15TSHRACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111295382-B Bridged bicyclic compounds as farnesyl ester X receptor modulators 百时美施贵宝公司 2024-02-02 CN claimed
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
CN-111295382-B Bridged bicyclic compounds as farnesyl ester X receptor modulators 百时美施贵宝公司 2024-02-02 CN disclosed
CN-1332942-C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2007-08-22 CN disclosed
WO-2007078184-A1 METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, HANYANG UNIVERSITY (KR) 2007-07-12 WO disclosed
CN-1703397-A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2005-11-30 CN disclosed